Australia's most trusted
source of pharma news
Friday, 08 August 2025
Posted 5 August 2025 PM
More details are emerging about MSD's US$3 billion cost-cutting program with the company revealing it will shed 6000 jobs or about eight per cent of its global workforce.
The 'multiyear optimisation initiative' was announced during MSD's second quarter results last week but the number of jobs to go was not specified at that time.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.